Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J3285 Treprostinil injection

J Codes (Drugs)

Also known as: treprostinil, Remodulin, prostacyclin analog

Treprostinil injection is a prostacyclin analog used for pulmonary arterial hypertension via subcutaneous infusion to improve exercise capacity and hemodynamics.

In Plain Language

lung pressure medication; pulmonary hypertension injection

Clinical Context

Indicated for pulmonary arterial hypertension to reduce symptoms and delay disease progression. Administered via continuous subcutaneous infusion or intravenous infusion. Improves exercise capacity and hemodynamics in pulmonary arterial hypertension.

RVU Information

CPT J3285 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

PulmonologyCardiologyCritical Care

Frequently Asked Questions

What is CPT code J3285?

CPT J3285 (Treprostinil injection) is a J Codes (Drugs) code. Treprostinil injection is a prostacyclin analog used for pulmonary arterial hypertension via subcutaneous infusion to improve exercise capacity and hemodynamics.

How is J3285 administered?

CPT J3285 is administered by a healthcare provider, typically via injection or infusion. Indicated for pulmonary arterial hypertension to reduce symptoms and delay disease progression. Administered via continuous subcutaneous infusion or intravenous infusion. Improves exercise capacity and hemodynamics in pulmonary arterial hypertension. It is used by Pulmonology, Cardiology, Critical Care.

When is CPT J3285 used?

Indicated for pulmonary arterial hypertension to reduce symptoms and delay disease progression. Administered via continuous subcutaneous infusion or intravenous infusion. Improves exercise capacity and hemodynamics in pulmonary arterial hypertension.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.